Financial writer Rich Duprey argues investors should be wary of buying into Anthropic’s anticipated IPO despite its roughly $1 trillion valuation target. He points to recent high-profile tech listings, including SpaceX and SK Hynix, both of which fell sharply after debuting despite enormous private-market demand. His core argument is that strong private valuations do not guarantee a good public entry price, and that buying at the opening price risks overpaying for years of anticipated growth that may not materialize.
